English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/209048
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorSoler, Maríaes_ES
dc.contributor.authorLechuga, Laura M.es_ES
dc.date.accessioned2020-04-25T11:56:37Z-
dc.date.available2020-04-25T11:56:37Z-
dc.date.issued2019-
dc.identifier.citationEuropean Medical Journal Oncology 4(4): 124-132 (2019)es_ES
dc.identifier.urihttp://hdl.handle.net/10261/209048-
dc.description.abstractAn increasing number of cancer patients have found new hope in the form of recently discovered cell immunotherapies. These novel treatments empower our own immune system to fight and eradicate the malignant tumours, even in metastatic stages. Unprecedented outcomes have been demonstrated with bioengineered cells especially modified in laboratories to trigger a highly specific and active anti-tumour function; however, a main bottleneck for the implementation of these promising therapies resides in the old-fashioned and limited techniques employed for the in vitroanalysis and study of cells during manufacturing and testing processes. Optical label-free biosensors are currently arising as promising analytical technologies for a simplified and accurate cell analysis. In particular, biosensors based on evanescent field principles enable direct, non-invasive, and real-time monitoring of biological events, showing outstanding sensitivities and excellent robustness. Furthermore, these biosensors are easily incorporated in lab-on-a-chip platforms for simple operation and implementation in clinical laboratories. In this review, the authors present and discuss the more recent research aimed to develop label-free optical biosensors for the analysis of live cells and the direct benefits offered to cell immunotherapy production allowing for its widespread implementation.es_ES
dc.description.sponsorshipThe authors acknowledge the financial support from PreDICT project (Programa estatal de investigación, desarrollo e innovación orientada a los Retos de la Sociedad, TEC2016-78515-R). ICN2 is the recipient of Grant SEV-2017-0706 from the “Severo Ochoa Centers of Excellence” Program of Spanish Ministry of Science.es_ES
dc.language.isoenges_ES
dc.publisherEuropean Medical Journales_ES
dc.relationMINECO/ICTI2013-2016/TEC2016-78515-Res_ES
dc.relationMICIU/ICTI2017-2020/SEV-2017-0706es_ES
dc.relationSEV-2017-0706/AEI/10.13039/501100011033es_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rightsopenAccesses_ES
dc.titleBoosting cancer immunotherapies with optical biosensor nanotechnologieses_ES
dc.typeartículoes_ES
dc.description.peerreviewedPeer reviewedes_ES
dc.identifier.e-issn2054-619X-
dc.rights.licensehttps://creativecommons.org/licenses/by-nc/4.0/es_ES
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España)es_ES
dc.contributor.funderAgencia Estatal de Investigación (España)es_ES
dc.relation.csices_ES
oprm.item.hasRevisionno ko 0 false*
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100011033es_ES
Appears in Collections:(CIN2) Artículos
Files in This Item:
File Description SizeFormat 
BoostingNanotech.pdf2,3 MBAdobe PDFThumbnail
View/Open
Show simple item record
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.